Form 8-K - Current report:
SEC Accession No. 0002007919-24-000054
Filing Date
2024-11-04
Accepted
2024-11-04 16:36:08
Documents
13
Period of Report
2024-11-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K inhibrx-20241104.htm   iXBRL 8-K 24796
  Complete submission text file 0002007919-24-000054.txt   156160

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT inhibrx-20241104.xsd EX-101.SCH 1809
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT inhibrx-20241104_lab.xml EX-101.LAB 23449
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT inhibrx-20241104_pre.xml EX-101.PRE 13596
15 EXTRACTED XBRL INSTANCE DOCUMENT inhibrx-20241104_htm.xml XML 2930
Mailing Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037
Business Address 11025 N. TORREY PINES ROAD, SUITE 140 LA JOLLA CA 92037 (858) 795-4220
Inhibrx Biosciences, Inc. (Filer) CIK: 0002007919 (see all company filings)

EIN.: 990613523 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-42031 | Film No.: 241424153
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)